Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovascular Response to Maternal Hyperoxygenation in Fetal Congenital Heart Disease

NCT03147014 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.

NCT NCT03147014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03147014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovascular Response to Maternal Hyperoxygenation in Fetal Congenital Heart Disease
Lead sponsor
Beijing Anzhen Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2016
Completion date
December 31, 2022
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic coarctation, atrial septal aneurysm, hypoplastic left heart syndrome